FDA panel endorses booster shot for J&J COVID-19 vaccine

U.S. health advisers endorsed a booster of Johnson & Johnson's COVID-19 vaccine Friday, citing concern that Americans who got the single-dose shot aren't as protected as those given two-dose brands.


FDA panel takes up tough questions on J&J COVID-19 boosters

U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when—and whether using a competing brand for the second dose might provide better protection.


FDA questions strength of Johnson & Johnson's booster shot data

In a development that could mean Johnson & Johnson might encounter resistance over its application for authorization of a booster shot of its coronavirus vaccine, a new analysis filed by the U.S. Food and Drug Administration ...


More questions for J&J vaccine boosters ahead of FDA review

The Food and Drug Administration is wrestling with whether and when to offer another dose of the single-shot Johnson & Johnson COVID-19 vaccine, while a new study out Wednesday raises the prospect that using a different brand ...


Next on FDA's agenda: Booster shots of Moderna, J&J vaccines

With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it's their turn.

Medical economics

Paper urges wealthy nations to delay COVID-19 boosters

High-income nations should heed the World Health Organization's calls to delay COVID-19 vaccine boosters until 10% of people in every country are vaccinated, two bioethicists say in a paper published today.

page 1 from 14